认知行为疗法干预减少1型糖尿病年轻成人低血糖恐惧(FREE):随机对照试验研究方案
本研究为一项随机对照试验方案,计划纳入50名18至35岁1型糖尿病年轻成人,随机分为FREE干预组(8周个体化认知行为疗法联合暴露治疗)或注意力对照组(8周个体化糖尿病自我管理教育)。主要目的是评估FREE干预的可行性与可接受性,并比较两组在低血糖恐惧、自我管理、糖化血红蛋白和血糖变异性方面的差异。
要点
- 针对1型糖尿病年轻成人低血糖恐惧(FOH)的认知行为疗法(CBT)干预方案。
- 采用随机对照设计,干预组接受8周个体CBT联合暴露治疗,对照组接受8周糖尿病自我管理教育。
- 主要结局包括FOH、自我管理行为、糖化血红蛋白(A1C)和实时连续葡萄糖监测(RT-CGM)记录的血糖变异性。
核心结论
- 该研究方案旨在评估FREE干预减少1型糖尿病年轻成人低血糖恐惧的可行性与可接受性,并为后续大型试验奠定基础。
研究设计与样本
- 随机对照试验,计划纳入50名18至35岁1型糖尿病年轻成人,随机分配至FREE干预组或注意力对照组。
- 干预组接受8周每周1次、每次1小时的个体化CBT联合暴露治疗,对照组接受8周每周1次、每次1小时的糖尿病自我管理教育。
- 研究包含1周导入期,基线测量低血糖恐惧、自我管理行为、A1C和RT-CGM记录的血糖变异性。
关键数值与推荐
- 低血糖定义为血糖水平低于70 mg/dl。
- 干预组使用RT-CGM和每日低血糖恐惧日记作为FREE项目的反馈线索。
- 对照组佩戴RT-CGM设备仅用于测量血糖变异性,持续8周。
局限性
- 该研究为试点研究方案,样本量50人,主要评估可行性与可接受性,而非疗效确证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In persons with type 1 diabetes (T1D), hypoglycemia is the major limiting factor in achieving optimal glycemic control. All persons with T1D are at risk for hypoglycemia (blood glucose level < 70 mg/dl), which is life-threatening and accompanied by serious physical and psychological symptoms, resulting in profound fear of hypoglycemia (FOH) and reduced quality of life. Young adults with T1D are at risk for FOH and have worse glycemic control and self-management behavior than other age groups with T1D. FOH also results in increased glycemic variability (GV). A major gap exists in how to manage FOH. Our overall objective is to reduce FOH and improve diabetes self-management, glycemic control, and GV in young adults with T1D to reduce or delay diabetes complications and improve quality of life. We aim to (1) determine the feasibility and acceptability of an eight-week cognitive behavioral therapy (CBT)-based Fear Reduction Efficacy Evaluation (FREE) intervention in young adults with T1D who experience FOH; and (2) determine the impact of the FREE intervention, compared to an attention control group, on the outcomes FOH, self-management, glycemic control (A1C), and glycemic variability (continuous glucose monitoring recordings). METHODS/DESIGN: A randomized controlled trial in 50 young adults aged 18 to 35 years with T1D will be used. Eligible subjects will be randomized to the intervention program (Fear Reduction Efficacy Evaluation [FREE]) or attention control group. A one-week run-in phase is planned, with baseline measures of FOH, self-management behavior, A1C, and real-time continuous glucose monitoring recordings (RT-CGM) to calculate GV for both groups. The intervention group will participate in eight weekly individual one-hour sessions using CBT and exposure treatment for specific fears. RT-CGM and a daily FOH diary will be used as feedback cues as part of the FREE program. The attention control group will participate in eight weekly individual one-hour diabetes self-management education (DSME) sessions and wear a RT-CGM device (to measure GV only) over 8 weeks. At completion, FOH will be measured, and RT-CGM recordings will be analyzed to determine differences between the FREE and control groups. DISCUSSION: Findings from this proposed pilot study will serve as the foundation for a larger trial to reduce FOH and improve self-management, glycemic control, and GV. TRIAL REGISTRATION: ClinicalTrials.gov: A cognitive behavioral therapy (CBT) intervention to reduce fear of hypoglycemia in type 1 diabetes, NCT03549104. Registered June 7, 2018.
引用
- Martyn-Nemeth P, Duffecy J, Quinn L, et al. A cognitive behavioral therapy intervention to reduce fear of hypoglycemia in young adults with type 1 diabetes (FREE): study protocol for a randomized controlled trial. Trials. 2019. PMID: 31888691. doi:10.1186/s13063-019-3876-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。